TLR4 and phosphorylcholine are co‐localized in the infarct area following unreperfused MI, suggesting phosphorylcholine to be a ligand for TLR4 signalling in the infarcted myocardium, endorsing PC‐mAb as a potential post‐ischaemic therapy. This evidence concerns the gene TLR4 and myocardial infarction.